Scholars Central

Conference abstractPublished 2015

Use of heterogeneous differentiated mesenchymal stem as a cirrhotic liver cell therapy of: A canine model experimental study

Authors: Marwa Hamdi El-Khashab, Elham A Hassan, Omar S El-Tookhy, Sabry D Abd Elfatah, Gehan G Shehab, Ashraf A Shamaa

Cairo University, Egypt Animal Health Research Institute, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Liver cirrhosis represents the final and the most common pathway of all chronic hepatic injury and is considered a worldwide health problem as liver slowly deteriorates and malfunctions and scar tissue replaces the healthy hepatocytes. The liver has the amazing potential to regenerate by its own hepatocytes when mild liver damage occurs but due to persistent and severe liver damage, hepatocytes no longer have the capacity to proliferate. Major advances have been made in the prevention, diagnosis and treatment of liver cirrhosis including liver transplantation and artificial liver. The ideas of complementing or replacing the damaged liver cells through cell-based therapies (stem cell) have been an extremely promising therapeutic agent for tissue regeneration in recent years. This study was applied on eighteen dogs as a model of cirrhotic liver treated with heterogeneous differentiated stem cells intraportal vein under ultrasonographic guidance. Induction of cirrhosis wascarried out via the administration of carbon tetrachloride (CCl4). Dogs were divided into two groups, Group-1: CCl4 with non MSCs treatment and Group-2:CCl4with MSCs treatment. Liver function was assessed by determination of liver function tests, hepatic ultrasonography with measuring of portal and hepatic veins diameters and finally liver biopsy. Liver function tests, hepatic ultrasonography, portal and hepatic veins diameter and histopathological properties demonstrated that hepatic cirrhosis was successfully established in dogs. After stem cells transplanted, there was a significant reversalin liver function tests, ultrasound findings, histopathological properties and portal and hepatic veins diameter (P<0.05).

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Regenerative Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Regenerative Medicine
  • SubjectEngineering
  • BylineArticles whose byline prints “Marwa Hamdi El-Khashab”
  • BylineArticles whose byline prints “Elham A Hassan”
  • BylineArticles whose byline prints “Omar S El-Tookhy”
  • BylineArticles whose byline prints “Sabry D Abd Elfatah”
  • BylineArticles whose byline prints “Gehan G Shehab”
  • BylineArticles whose byline prints “Ashraf A Shamaa”